Metri Bio

Raised $5M in a Pre-Seed round, announced 2 December 2025.

Round

Funds to scale its discovery platform, expand the team and move toward preclinical studies.

Amount
$5M
Stage
Pre-Seed
Announced
2 December 2025
Lead
Pillar VC
Other investors
Pace Ventures, Slocum Management, Navec Investments
Use of funds
Funds to scale its discovery platform, expand the team and move toward preclinical studies.
Checked
Amount and date matched across 2 press sources

Company

Develops therapies for endometriosis and other endometrial diseases using a 3D endometrial model from Yale

Based in
Boston, United States
Sector
Health
Website
metri.bio ↗

Sources and links

Sources
Metri Bio: $5 Million Pre-Seed Secured To Advance Next-Generation Endometriosis Therapeutics - Pulse 2.0 femtechinsider.com
Metri Bio: $5 Million Pre-Seed Secured To Advance Next-Generation Endometriosis Therapeutics - Pulse 2.0 news.google.com
Website
metri.bio ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost